Aquestive Therapeutics Inc (AQST)

Capital Expenditure

-$212.00K

Quarterly · Period ending: · USD

AQST logo

AQST Capital Expenditure

Latest reported-$212.00K
AQST Quarterly CapEx (-$657.00K → -$212.00K)
High-resolution chart · PNG

AQST capital expenditure history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aquestive Therapeutics Inc Capital Expenditure — Quarterly (USD)
Period endingCapital Expenditure (USD)
-212,000
-52,000
-85,000
-235,000
-107,000
-135,000
-15,000
-80,000
-35,000
-29,000
-16,000
-151,000
-826,000
-2,000
-26,000
-1,717,000
-677,000
-104,000
-533,000
-83,000
-194,000
-103,000
-236,000
-38,000
-112,000
-131,000
-86,000
-91,000
-110,000
-376,000
-490,000
-448,000
-627,000
-259,000
-88,000
-433,000
-890,000
-657,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.